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Epithelial migration, which is a fundamental component of the ulcer
healing process, is characterized by complex alterations in adhesion
between cells and the extracellular matrix. Growth and motility factors
involved in mucosal repair ofthe gastrointestinal tract seem to modulate
these interactions in a coordinated fashion in order to reestablish func-
tional and structural integrity of the mucosa. These findings may have
important clinical implications forthe treatment ofulcerative conditions
of the gastrointestinal tract and lead to the development of specific
drugs that promote mucosal healing by exploiting natural mechanisms
of cell migration.
INTRODUCTION
Epithelial restitution is a fundamental protective mechanism that allows the gastroin-
testinal mucosa to re-establish functional and structural integrity following superficial
injury [1]. This repairing mechanism is characterized by rapid migration of surviving
epithelial cells around the ulcer margins over the denuded basement membrane. During
this phase, there appears to be no cell division [2]. Subsequently, cell proliferation and dif-
ferentiation occur to reestablish normal function and tissue architecture. In animal stud-
ies, following superficial damage of the gastric mucosa, this process may occur within a
very short time span (within one hour) [3].
It is now apparent that changes in cell-cell and cell-matrix interactions occur spatial-
ly and temporally during migration [4]. Several families of adhesion receptors, which
mediate the interaction between adjacent epithelial cells or between cells and the sur-
rounding extracellular matrix (ECM)b, have been shown to regulate migration [5]. A
detailed description of the genetic, biochemical structure and function of adhesion mole-
cules is beyond the scope ofthis paper. Here I describe data on the part played by soluble
factors known to promote epithelial restitution and mucosal healing in the modulation of
cell adhesion.
THE ROLE OFADHESION MOLECULES IN
EPITHELIAL CELL MIGRATION
Cell motility requires dynamic interactions between cells, their extracellular envi-
ronment and the cytoskeletal network. The initiation and progression of epithelial cell
migration require the release ofthe adhesive tractions between epithelial cells and estab-
lishment of stable cell-substratum adhesion to generate traction and movement forward.
It is likely that the transition from a "stationary" to a "motile" cell requires perturbation
of cell junctional proteins like E-cadherin/catenin complex and the modulation of
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expression, affinity and binding specificity of extracellular matrix adhesion receptors
(e.g., integrins).
E-cadherin
Epithelial cadherin is the prime mediator of cell-cell adhesion in epithelial cells [6].
It is a 120 kDa polypeptide and belongs to the cadherin superfamily, a group of over 16
molecules that all have common structural and functional characteristics [7]. All family
members are transmembraneglycoproteins, which bind asingle calcium ion attheir extra-
cellular amino terminal end. Loss of this ion prevents cell-cell adhesion. Typically a sin-
gle cadherin molecule binds homotypically to another cadherin molecule ofthe same type
on an adjacent cell to form a homodimer [7]. The carboxy terminal cytoplasmic tail inter-
acts with various cytoplasmic proteins (termed catenin complex), which in turn binds to
the actin cytoskeleton [8].
The catenin complex was originally dissected by immunoprecipitating E-cadherin
from metabolically labeled cell extracts and analyzing the coprecipitating molecules
whose genes were subsequently cloned [9]. The catenin complex consists of a-catenin
(102 kDa), P-catenin (92 kDa) and y-catenin (88 kDa). There is evidence that E-cadherin
binds to either ,-catenin or y-catenin [8], whereas a-catenin links 13-catenin to the actin
cytoskeleton via direct association with a-actinin [10]. The catenins also bind to other
molecules including the epidermal growth factor receptor (EGFR) [11] and the adenoma-
tous polyposis coli tumor suppressor geneproduct [12, 13] and may be involved in growth
regulatory signalling as well as cell adhesion [14]. Mutations or deletion of any ofthe E-
cadherin/catenin complex components renders the cell unable to form calcium-dependent
adhesions, leads to loss of cell polarity and increased cell motility in vitro [6]. Catenins
also contain tyrosine residues known to be phosphorylated by oncogene products (e.g.,
src, ras, fos and met) and growth factors. Under these conditions, there is destabilization
of the adhesionjunctions with perturbation ofintercellular adhesion [15, 16, 17, 18, 19].
Integrins
These are a family oftransmembrane glycoproteins composed of an a and a f chain,
which are associated to the actin cytoskeleton through linker proteins such as talin, vin-
culin and a-actinin [20]. The distribution of integrins on normal and neoplastic cells has
been mapped using monoclonal antibodies to the sub-units and shows acharacteristic cell-
lineage-dependent pattern. Most of the integrins function as cell surface receptors for
extracellular matrix components including collagen, laminin and fibronectin. However,
thepicture is complex as the gastrointestinal epithelium expresses multiple integrin recep-
tors (i.e., a2p1l, a31l, a6t1, avf3l, avf35) with overlapping specificity [21, 22]. Integrins
have been implicated in the regulation ofcell migration in a variety of systems [22]. For
example, we have recently shown that a2f1 integrin receptor mediates migration of
colonic carcinoma cell lines on collagen [24]. This has been also demonstrated in other
cell types [23]. Recently, knock-out ofJ1 integrin gene in embryonic stem cells has shown
to inhibit cell migration and adhesion [25].
THE ROLE OF GROWTH-MOTILITY FACTORS IN
CELL ADHESION DURING EPITHELIAL RESTITUTION
We have recently shown that perturbation ofE-cadherin/catenin mediated adhesion
is associated with epithelial migration and restitution following ulceration of the gas-
trointestinal tract [26]. Using immunohistochemical and in situ hybridization tech-
niques, we have shown that in Crohn's disease and gastric ulcer, the regenerative epithe-
lium over the ulcer bases shows loss of the normal membrane E-cadherin immunoreac-
tivity with an abnormal cytoplasmic localization. Using a wounding monolayer in vitro
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system, migratory cells also showed reduced surface E-cadherin expression with abnor-
mal cytoplasmic immunoreactivity. Cytoplasmic E-cadherin is likely to reflect a non-
functional molecule since E-cadherin needs to be expressed on the membrane to medi-
ate cell-cell adhesion. These results, therefore, indicate that changes in the E-cadherin
subcellular localization and level ofexpression occur in the regenerative epithelium in a
variety ofdisease states and may promote the transition from a "stationary" to a "motile"
phenotype. How are these dynamic interactions controlled during epithelial restitution?
Several growth factors may be involved in gastric mucosal repair. Epidermal growth
factor (EGF) and transforming growth factor-a (TGF-a) are two homologous peptides
that bind to the same receptor (EGFR) and have been implicated in gastric ulcer healing
[27]. For example, animal studies have shown that recombinant EGF can protect against
the development of gastric ulcerations following indomethacin treatment [28]. In vitro,
both EGF and TGF-a promote cell migration and proliferation through the regulation of
adhesion receptor function. We and other groups have shown that EGF and TGF-a stim-
ulate adhesion and migration of colonic epithelial cells on laminin and collagen [29, 30].
Both growth factors up-regulate the functional activity of at least two integrin molecules
(a21l and a31l), which are receptors for laminin and collagen. The cell attachment and
migration induced by TGF-a and EGF can be inhibited by monoclonal antibodies to the
a2 and J1 integrin chains [29, 30]. EGF has been shown to induce rapid tyrosine phos-
phorylation of P-catenin and y-catenin. This is associated with scattering and dispersion
ofepithelial cells and loss ofE-cadherin from the cell-celljunctions [18, 19]. Growth fac-
tor signalling through EGFR is, therefore, an example of how the transition from a "sta-
tionery" to a "motile" cell is mediated by reduction of cell-cell adhesion and increased
binding to the extracellular matrix.
Trefoil peptides are a highly conserved family ofmolecules that are locally produced
at sites ofgastrointestinal injury, promote mucosal regeneration and healing [31]. They are
small, secretory, stable peptides, bearing one or more trefoil structural motifs. They are
expressed in specific regions ofthe gut in association with mucins [32]. To date, three tre-
foil peptides have been identified in humans. These are the human spasmolytic polypep-
tide, intestinal trefoil factor and pS2 [31]. In vitro, they have all been shown to promote
cell motility, but they do not stimulate cell division in contrast to other motogenic factors
such as EGF and TGF-oc [28, 33, 34, 35]. Intestinal trefoil factor and human spasmolytic
polypeptide have also been shown to initiate cell motility by perturbing the E-
cadherin/catenin adhesion complex.
Hepatocyte growth factor/Scatter factor (HGF/SF) is also a growth and motility fac-
tor, which is primarily produced by cells ofmesenchymal origin but stimulates the motil-
ity and scattering ofepithelial cells [36]. HGF/SF triggers cell migration on various extra-
cellular matrix substrates. Matsumoto et al. [36] have shown that HGF/SF stimulates
motility in a two-step process: initially cells spread rapidly and form focal adhesions, and
then these are rapidly disassembled, followed by increased cell motility [37]. Migration
and proliferation of gastric epithelial cells in vitro has been shown to be facilitated by
exogenous HGF/SF. In vivo, HGF/SF mRNA and protein have been localized in the
fibroblasts around gastric ulcers but not in gastric epithelial cells, suggesting that it acts in
aparacrine fashion [38]. As shown forEGF, phosphorylation of,3-catenin by HGF/SF per-
turbs the E-cadherin/catenin adhesion complex and stimulates cell migration [18]. ,B-
catenin phosphorylation, therefore, seems to be a common mechanism by which soluble
factors involved in epithelial restitution may induce migration and regeneration.
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CONCLUSIONS
Epithelial migration, which is a fundamental component ofthe ulcer healing process,
is characterized by complex alterations in adhesion between cells and the extracellular
matrix. Growth and motility factors involved in mucosal repair ofthe gastrointestinal tract
seem to modulate these interactions in a coordinated fashion in order to reestablish func-
tional and structural integrity of the mucosa. These findings may have important clinical
implications for the treatment ofulcerative conditions ofthe gastrointestinal tract and lead
to the development of specific drugs that promote mucosal healing by exploiting natural
mechanisms of cell migration.
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